Asepha develops a stack of interoperable AI agents that streamline pharmacy workflows and reduce administrative burden. Its product suite includes an OCR prescription-entry agent with 96% accuracy, a call agent that automates up to 70% of inbound phone calls, and a browser-navigation agent for real-time web tasks. Validation experiments found pharmacists preferred Asepha’s AI responses over a human pharmacist’s responses 71% of the time in a double-blinded randomized trial. The company targets pharmacies facing acute staffing shortages—about 70% of pharmacies are understaffed and pharmacists spend as much as 90% of their time on analog administrative work. Asepha has secured multiple Fortune 50 enterprise customers, demonstrating early commercial traction. With the new funding it plans to grow engineering and go-to-market teams, expand global partnerships, and increase its U.S. footprint with a New York City office.

Total raised

$4M

Funding rounds

1

Latest round

Seed

Latest activity

Jul 2025